Oncology

Photo

Article • RFA, MWA, CRYO and IRE under scrutiny

Thoracic interventions: new tools in the arsenal

Experts presented state-of-the-art and emerging techniques to treat chest tumours and discussed common issues in the management of pneumothorax at RSNA 2022. Current ablation methods in the thorax include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation (CRYO), irreversible electroporation (IRE) and pulsed electric field.

Photo

Article • Cancer patients at risk

Blood test detects risk of neurotoxicity from CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy treatment that re-engineers a patient’s own T-cells to help them attack malignant tumour cells. It has been very effective in the treatment of blood cancers, including certain types of leukaemia and lymphoma. However, two serious side effects are common as a result of the treatment: cytokine release syndrome (CRS) and immune…

Photo

Article • Progress, limitations, and opportunities

Precision oncology: incredible potential, but not a miracle cure

Unanswered questions are hampering clinicians in their efforts to get the best out of a precision medicine approach for their patients. Speaking at the Genomics and Precision Medicine Expo in London at the end of May, cancer educator Dr Elaine Vickers said the benefits of being matched to an investigational drug remain questionable for most people with advanced cancer.

Photo

Article • Existing solutions need to mature, experts find

Interactive mobile cancer apps: promising, but formative

Interactive mobile apps have become ubiquitous in daily life. The Covid-19 pandemic has escalated the use of disease-specific monitoring apps. Mobile apps enabling cancer patients to self-manage their physical condition and symptoms can help them to evaluate toxic side effects of their treatments, offer artificial intelligence (AI)-generated recommendations to minimize them, and alert them to…

Photo

Article • Mid-treatment scans can reduce treatment sessions

De-escalating radiation therapy for oropharynx cancer with FDG-PET

Using fluorodeoxyglucose positron emission tomography (FDG-PET) imaging may give insights into possible dose reductions in ongoing radiation therapy of head and neck cancer. A promising study to explore this option was presented at the 2022 ASTRO/ASCO Multidisciplinary Head and Cancer Symposium held in Phoenix, Arizona.

Photo

Article • AI-based personalized medical care

I³lung: EU launches lung cancer initiative

This summer, The European Commission launched I3lung, a new research initiative as a part of Horizon Europe, the EU’s research and innovation program. This research initiative aims to create a cutting-edge, decision-making tool to help clinicians and patients select the best lung cancer treatment based on each patient’s specific needs and circumstances.

351 show more articles
Subscribe to Newsletter